Karo Pharma completes the acquisition of the E45® brand from Reckitt
Karo Pharma Aktiebolag (“Karo”) has today completed the previously announced acquisition of the skin health brand, E45®, from Reckitt for a total consideration of GBP 200m. All conditions to the completion of the transaction have been satisfied.Net sales of E45® was GBP 43m in 2021 and the transaction contributes positively to Karo’s market position within skin health, particularly in the UK, South Africa and Spain. “E45 is a unique brand, which is trusted by consumers and represents quality and consistency, and we see compelling opportunities to unlock value and develop the brand via